Evidence map›Paper›PMID 30458917›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.

Diamantis Plachouras, Tommi Kärki, Sonja Hansen, Susan Hopkins, Outi Lyytikäinen, Maria Luisa Moro, Jacqui Reilly, Peter Zarb, Walter Zingg, Pete Kinross and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 119 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Observational
  9. Article
  10. Beyond the Reported Numbers:Antibiotics (Basel, Switzerland) · 2026
    Article
  11. Review
  12. Current status and future perspectives of fecal immunological markers in the differential diagnosis of Clostridioides difficile infection in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  13. First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Short course of antimicrobial treatment for uncomplicated enterococcal bacteremia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Diamantis PlachourasEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Tommi KärkiEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Sonja HansenInstitute of Hygiene and Environmental Medicine, Charité - University Medicine Berlin, Berlin, Germany.
Susan HopkinsPublic Health England, London, United Kingdom.
Outi LyytikäinenNational Institute for Health and Welfare (THL), Department of Health Security, Helsinki, Finland.
Maria Luisa MoroAgenzia sanitaria e sociale regionale - Regione Emilia Romagna, Bologna, Italy.
Jacqui ReillyNational Services Scotland, Health Protection Scotland, Glasgow, United Kingdom.
Peter ZarbMater Dei Hospital, Msida, Malta.
Walter ZinggImperial College, London, United Kingdom.
Pete KinrossEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Klaus WeistEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Dominique L MonnetEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Carl SuetensEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Point Prevalence Survey Study GroupMembers of the Point Prevalence Survey Study Group are listed at the end of this article.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial agents used to treat infections are life-saving. Overuse may result in more frequent adverse effects and emergence of multidrug-resistant microorganisms. In 2016-17, we performed the second point-prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals. We included 1,209 hospitals and 310,755 patients in 28 of 31 European Union/European Economic Area (EU/EEA) countries. The weighted prevalence of antimicrobial use in the EU/EEA was 30.5% (95% CI: 29.2-31.9%). The most common indication for prescribing antimicrobials was treatment of a community-acquired infection, followed by treatment of HAI and surgical prophylaxis. Over half (54.2%) of antimicrobials for surgical prophylaxis were prescribed for more than 1 day. The most common infections treated by antimicrobials were respiratory tract infections and the most commonly prescribed antimicrobial agents were penicillins with beta-lactamase inhibitors. There was wide variation of patients on antimicrobials, in the selection of antimicrobial agents and in antimicrobial stewardship resources and activities across the participating countries. The results of the PPS provide detailed information on antimicrobial use in European acute care hospitals, enable comparisons between countries and hospitals, and highlight key areas for national and European action that will support efforts towards prudent use of antimicrobials.

Indexed as

Anti-Infective Agentsbeta-Lactamase InhibitorsCommunity-Acquired InfectionsCross InfectionDrug PrescriptionsDrug UtilizationFemaleHospitalsHumansIntensive Care UnitsMalePenicillinsRespiratory Tract InfectionsSurveys and QuestionnairesAnti-Infective Agentsbeta-Lactamase InhibitorsPenicillinsantibiotic useantimicrobial usehealthcare-associated infectionshospitalspoint-prevalence surveysurveillance

Identifiers

PMID30458917
PMCPMC6247463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.